Characteristics of eyes with secondary loss of visual acuity receiving variable dosing Ranibizumab for neovascular age-ralated macular degeneration


Autoria(s): Mariani A.
Contribuinte(s)

Mantel, I.

Deli, A.

Ambresin, A.

Data(s)

2012

Formato

10

Identificador

http://serval.unil.ch/?id=serval:BIB_D41BF0299AC0

reroid:R007329908

http://my.unil.ch/serval/document/BIB_D41BF0299AC0.pdf

http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D41BF0299AC03

Idioma(s)

en

Publicador

Faculté de biologie et de médecineUniversité de LausanneUNIL - BugnonRue du Bugnon 21 - bureau 4111CH-1015 LausanneSUISSE: Université de Lausanne, Faculté de biologie et médecine

Direitos

info:eu-repo/semantics/openAccess

Tipo

info:eu-repo/semantics/doctoralThesis

phdthesis